Journal of Pharmaceutical and Biomedical Analysis 2007-01-04

Quantification of antihistamine acrivastine in plasma by solid-phase extraction and high-performance liquid chromatography.

Benjamin R Collins, Xiaochen Gu

Index: J. Pharm. Biomed. Anal. 43(1) , 293-7, (2007)

Full Text: HTML

Abstract

An automated solid-phase extraction method was developed for the determination of the H1-antihistamine acrivastine in plasma samples. Acrivastine was analyzed at the wavelength of 254 nm using a reversed-phase HPLC assay. Both extraction procedure and analytical condition were optimized and validated for maximum recovery and resolution. The developed method was further applied to plasma samples collected from an in vivo pharmacokinetic study in rabbits. The assay was found to be simple, specific, accurate and reproducible.


Related Compounds

Related Articles:

Identification of novel functional inhibitors of acid sphingomyelinase.

2011-01-01

[PLoS ONE 6 , e23852, (2011)]

Simultaneous analysis of the H1-antihistamine acrivastine and the decongestant pseudoephedrine hydrochloride by high-performance liquid chromatography.

2005-04-01

[J. Pharm. Biomed. Anal. 37(4) , 663-7, (2005)]

Onset-of-action for antihistamine and decongestant combinations during an outdoor challenge.

2000-04-01

[Ann. Allergy Asthma Immunol. 84(4) , 451-9, (2000)]

Efficacy of acrivastine plus pseudoephedrine for symptomatic relief of seasonal allergic rhinitis due to mountain cedar.

1996-05-01

[Ann. Allergy Asthma Immunol. 76(5) , 432-8, (1996)]

Evaluation and comparison of five matrix excipients for the controlled release of acrivastine and pseudoephedrine.

2004-01-01

[Drug Dev. Ind. Pharm. 30(10) , 1009-17, (2004)]

More Articles...